Home
Conditions
Stage IV Melanoma

Clinical trial condition

Stage IV Melanoma

Explore clinical trials studying Stage IV Melanoma. Study availability and eligibility vary by location and protocol.

69 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Stage IV Melanoma trial results

Completed

Sorafenib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

NCT00119249

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: Montefiore Medical Center The Bronx, New York, United States

View Trial Details

Completed

Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma

NCT00438984

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma

NCT00003646

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +12 more
Locations: Mayo Clinic Cancer Center Rochester, Minnesota, United States

Roswell Park Cancer Institute Buffalo, New York, United States

Physician Reliance Network, Inc. Dallas, Texas, United States

View Trial Details

Completed

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

NCT00003647

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +12 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Comprehensive Blood and Cancer Center Bakersfield, California, United States

Scripps Memorial Hospitals-Stevens Cancer Center - Encinitas Encinitas, California, United States

Kaiser Permanente-Southern California Permanente Medical Group San Diego, California, United States

View all 44 locations

View Trial Details

Active, Not Recruiting

A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma

NCT04356729

Conditions: Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma, Neoplasms, +13 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer

NCT06416085

Conditions: Advanced Cancer, Endocrine Cancer, Endocrine Gland Neoplasms, +28 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Active, Not Recruiting

Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients

NCT05176470

Conditions: Locally Advanced Melanoma, Melanoma, Neoplasms, +14 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

Optimization of Immunotherapy Treatment for Advanced Melanoma in the Context of the Public Brazilian Health System (OTIMAS)

NCT07376317

Conditions: Cutaneous Melanoma, Melanoma, Melanoma Metastatic, +13 more
Locations: ICESP São Paulo, Brazil

View Trial Details

Active, Not Recruiting

Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib

NCT03235245

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: University Hospitals Copenhagen - Herlev Hospital - University Copenhagen Herlev, Denmark

Odense University Hospital Odense, Denmark

Helsinki University Central Hospital - Dept of Oncology Helsinki, Finland

Tampere University Hospital Tampere, Finland

View all 38 locations

View Trial Details

Stage IV Melanoma

Stage IV Melanoma trial results

Related conditions